|Distribution of disease categories|
|Groups||Findings and number of dogs|
|SRMA untreated (SRMA)||Dogs with fever, cervical pain, neutrophilic leukocytosis and pleocytosis. These dogs were not pre-treated with glucocorticosteroid (n = 36)|
|SRMA relapse (SRMA R)||Dogs with a previous diagnosis of SRMA in which clinical signs recurred despite glucocorticosteroid treatment (n = 9)|
|SRMA therapy (SRMA Th)||Dogs with previous diagnosis of SRMA under long-term glucocorticosteroid treatment. These dogs did not show any clinical signs at the time of sampling (n = 20)|
|Idiopathic epilepsy (IE)||Dogs with clinical, CSF, MRI findings consistent with idiopathic epilepsy (n = 22)|
|Meningoencephalomyelitides (ME)||Dogs with clinical, CSF, MRI and/or pathological findings consistent with meningoencephalomyelitides: granulomatous meningoencephalomyelitis (n = 14), necrotising encephalitides (n = 1), meningoencephalomyelitis of unknown origin (n = 8), infectious encephalitides (n = 24)|
|Miscellaneous non-inflammatory CNS diseases (CNS-Mix).||Dogs with miscellaneous not primarily inflammatory neurological diseases: intervertebral disc disease (n = 9), neoplasia of the CNS (n = 24), cerebrovascular disease (n = 4), degenerative myelopathy (n = 1)|
|Systemic inflammatory diseases (Syst. Inflam.)||Dogs affected with systemic inflammatory diseases, but not suffering from neurological conditions (n = 16)|
|Healthy||Healthy dogs (n = 20)|
CSF: cerebrospinal fluid; CNS: central nervous system; MRI: magnetic resonance imaging; SRMA: steroid-responsive meningitis-arteritis.
Maiolini et al.
Maiolini et al. BMC Veterinary Research 2013 9:23 doi:10.1186/1746-6148-9-23